Although artificial intelligence (AI) has demonstrated potential in automating glaucoma screening, there is still a significant obstacle in transferring research datasets to actual clinical settings.
Andrea Riquier is a former Staff Writer at Forbes Advisor. She is a New York-based writer covering mortgages and the housing market. She was previously at Dow Jones MarketWatch, on the housing market ...